Man Group’s Acutus Medical Inc AFIB Stock Holding History

Man Group’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,158	Closed	-$13K	–	2299
2022 Q3	$13K	Buy	+15,158	New	+$18.3K	﹤0.01%	1963

Other funds holding AFIB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

KSCM

Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's AFIB Position: Q4 2022 in Review

Man Group sold out of Acutus Medical Inc (AFIB) in Q4 2022, closing a stake of 15,158 shares — an estimated $13K sold.

Man Group first reported a position in AFIB in Q3 2022 and held it in 1 quarter. The position peaked at $13K in Q3 2022. 38 funds tracked by Wall St. Rank hold AFIB as of Q4 2022.

Man Group reported no remaining Acutus Medical Inc position as of Q4 2022 after selling out during the quarter.
Man Group sold 15,158 Acutus Medical Inc shares in Q4 2022, an estimated $13K.
Man Group first reported a position in Acutus Medical Inc in Q3 2022 and held it in 1 quarter.
Man Group's Acutus Medical Inc position peaked at $13K in Q3 2022.
38 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.